FREXYMKO
Live / Allowed — Publication / registration review complete (as of 18 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99759844
- Mark type
- Word mark
- Kind
- Trademark
- Register
- Principal
- Basis
- Intent to use (§1(b)) and foreign registration (§44(e))
- Filed
- 13 Apr 2026
- Published for opposition
- 08 Dec 2026
- Examining attorney
- John B. Regan
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, inflammatory and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, immune-mediated, inflammatory, immunological, central nervous system and neurological diseases and disorders
Owner
- Sanofi, Paris, FR
Prosecution history
- 09 Nov 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2026 — AMENDMENT FROM APPLICANT ENTERED
- 07 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Oct 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 20 Jun 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 20 Jun 2026 — LETTER OF SUSPENSION E-MAILED
- 20 Jun 2026 — SUSPENSION LETTER WRITTEN
- 16 Jun 2026 — ASSIGNED TO EXAMINER
- 28 Apr 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 28 Apr 2026 — ASSIGNED TO LIE
- 23 Apr 2026 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 13 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 13 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Apr 2026 — NEW APPLICATION ENTERED